Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

USA - NASDAQ:FRPT - US3580391056 - Common Stock

54.12 USD
-0.07 (-0.13%)
Last: 10/24/2025, 8:27:54 PM
54.5 USD
+0.38 (+0.7%)
After Hours: 10/24/2025, 8:27:54 PM
Fundamental Rating

5

Taking everything into account, FRPT scores 5 out of 10 in our fundamental rating. FRPT was compared to 87 industry peers in the Food Products industry. FRPT has an average financial health and profitability rating. FRPT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

FRPT had positive earnings in the past year.
FRPT had a positive operating cash flow in the past year.
In the past 5 years FRPT reported 4 times negative net income.
Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.04%, FRPT is in line with its industry, outperforming 45.98% of the companies in the same industry.
FRPT has a Return On Equity of 3.14%. This is comparable to the rest of the industry: FRPT outperforms 45.98% of its industry peers.
FRPT has a Return On Invested Capital of 2.84%. This is comparable to the rest of the industry: FRPT outperforms 49.43% of its industry peers.
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROIC 2.84%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

With a decent Profit Margin value of 3.23%, FRPT is doing good in the industry, outperforming 63.22% of the companies in the same industry.
FRPT has a better Operating Margin (5.38%) than 60.92% of its industry peers.
With an excellent Gross Margin value of 40.87%, FRPT belongs to the best of the industry, outperforming 94.25% of the companies in the same industry.
In the last couple of years the Gross Margin of FRPT has declined.
Industry RankSector Rank
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRPT is destroying value.
Compared to 1 year ago, FRPT has more shares outstanding
Compared to 5 years ago, FRPT has more shares outstanding
Compared to 1 year ago, FRPT has an improved debt to assets ratio.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.50 indicates that FRPT is not in any danger for bankruptcy at the moment.
FRPT has a Altman-Z score of 3.50. This is in the better half of the industry: FRPT outperforms 75.86% of its industry peers.
FRPT has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
FRPT has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACC0.37
WACC7.72%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

FRPT has a Current Ratio of 4.81. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.81, FRPT belongs to the best of the industry, outperforming 95.40% of the companies in the same industry.
FRPT has a Quick Ratio of 3.75. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.75, FRPT belongs to the best of the industry, outperforming 95.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.81
Quick Ratio 3.75
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.00%, which is quite impressive.
FRPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.30%.
The Revenue has been growing by 31.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%

3.2 Future

The Earnings Per Share is expected to grow by 32.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, FRPT will show a quite strong growth in Revenue. The Revenue will grow by 12.47% on average per year.
EPS Next Y19.06%
EPS Next 2Y47.21%
EPS Next 3Y41.59%
EPS Next 5Y32.76%
Revenue Next Year13.72%
Revenue Next 2Y13.3%
Revenue Next 3Y12.83%
Revenue Next 5Y12.47%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 53.06, which means the current valuation is very expensive for FRPT.
FRPT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.91, FRPT is valued quite expensively.
A Price/Forward Earnings ratio of 26.57 indicates a quite expensive valuation of FRPT.
The rest of the industry has a similar Price/Forward Earnings ratio as FRPT.
When comparing the Price/Forward Earnings ratio of FRPT to the average of the S&P500 Index (22.92), we can say FRPT is valued inline with the index average.
Industry RankSector Rank
PE 53.06
Fwd PE 26.57
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRPT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.35
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FRPT does not grow enough to justify the current Price/Earnings ratio.
FRPT's earnings are expected to grow with 41.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.78
PEG (5Y)N/A
EPS Next 2Y47.21%
EPS Next 3Y41.59%

More info and screens

0

5. Dividend

5.1 Amount

FRPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (10/24/2025, 8:27:54 PM)

After market: 54.5 +0.38 (+0.7%)

54.12

-0.07 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners119.43%
Inst Owner Change-0.03%
Ins Owners1.68%
Ins Owner Change0.28%
Market Cap2.64B
Revenue(TTM)1.04B
Net Income(TTM)33.68M
Analysts80.87
Price Target93.66 (73.06%)
Short Float %12.84%
Short Ratio4.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)73.73%
Min EPS beat(2)-9.66%
Max EPS beat(2)157.12%
EPS beat(4)2
Avg EPS beat(4)64.83%
Min EPS beat(4)-9.66%
Max EPS beat(4)157.12%
EPS beat(8)6
Avg EPS beat(8)129.92%
EPS beat(12)8
Avg EPS beat(12)86.35%
EPS beat(16)8
Avg EPS beat(16)40.73%
Revenue beat(2)0
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.14%
Revenue beat(16)7
Avg Revenue beat(16)-0.61%
PT rev (1m)-1.74%
PT rev (3m)-16.17%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)2.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.96%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-1.65%
Valuation
Industry RankSector Rank
PE 53.06
Fwd PE 26.57
P/S 2.53
P/FCF N/A
P/OCF 18.19
P/B 2.46
P/tB 2.46
EV/EBITDA 20.35
EPS(TTM)1.02
EY1.88%
EPS(NY)2.04
Fwd EY3.76%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.98
OCFY5.5%
SpS21.4
BVpS21.97
TBVpS21.97
PEG (NY)2.78
PEG (5Y)N/A
Graham Number22.45
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROCE 3.6%
ROIC 2.84%
ROICexc 3.37%
ROICexgc 3.37%
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 3.06
Cap/Depr 184.01%
Cap/Sales 14.58%
Interest Coverage 6.25
Cash Conversion 104.51%
Profit Quality N/A
Current Ratio 4.81
Quick Ratio 3.75
Altman-Z 3.5
F-Score8
WACC7.72%
ROIC/WACC0.37
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
EPS Next Y19.06%
EPS Next 2Y47.21%
EPS Next 3Y41.59%
EPS Next 5Y32.76%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%
Revenue Next Year13.72%
Revenue Next 2Y13.3%
Revenue Next 3Y12.83%
Revenue Next 5Y12.47%
EBIT growth 1Y247.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year389.58%
EBIT Next 3Y94.32%
EBIT Next 5Y59.23%
FCF growth 1Y96.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y666.43%
OCF growth 3Y519.17%
OCF growth 5Y56.72%

FRESHPET INC / FRPT FAQ

What is the ChartMill fundamental rating of FRESHPET INC (FRPT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRPT.


What is the valuation status of FRESHPET INC (FRPT) stock?

ChartMill assigns a valuation rating of 2 / 10 to FRESHPET INC (FRPT). This can be considered as Overvalued.


How profitable is FRESHPET INC (FRPT) stock?

FRESHPET INC (FRPT) has a profitability rating of 4 / 10.


Can you provide the financial health for FRPT stock?

The financial health rating of FRESHPET INC (FRPT) is 6 / 10.


What is the earnings growth outlook for FRESHPET INC?

The Earnings per Share (EPS) of FRESHPET INC (FRPT) is expected to grow by 19.06% in the next year.